128 related articles for article (PubMed ID: 19258483)
1. HFE C282Y mutation as a genetic modifier influencing disease susceptibility for chronic myeloproliferative disease.
Andrikovics H; Meggyesi N; Szilvasi A; Tamaska J; Halm G; Lueff S; Nahajevszky S; Egyed M; Varkonyi J; Mikala G; Sipos A; Kalasz L; Masszi T; Tordai A
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):929-34. PubMed ID: 19258483
[TBL] [Abstract][Full Text] [Related]
2. Association of HFE mutations (C282Y and H63D) with iron overload in blood donors from Mexico City.
Baptista-González HA; Rosenfeld-Mann F; Trueba-Gómez R; Bermejo-Martínez L; Méndez-Sánchez N
Ann Hepatol; 2007; 6(1):55-60. PubMed ID: 17297430
[TBL] [Abstract][Full Text] [Related]
3. [Study on HFE gene mutations in patients with myelodysplastic syndromes and aplastic anemia].
Nie L; Ai XF; Zheng YZ; Li QH; Yang L; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2009 Apr; 30(4):223-8. PubMed ID: 19731820
[TBL] [Abstract][Full Text] [Related]
4. HFE genotype and parameters of iron metabolism in German first-time blood donors - evidence for an increased transferrin saturation in C282Y heterozygotes.
Raddatz D; Legler T; Lynen R; Addicks N; Ramadori G
Z Gastroenterol; 2003 Nov; 41(11):1069-76. PubMed ID: 14648375
[TBL] [Abstract][Full Text] [Related]
5. Metabolic alterations, HFE gene mutations and atherogenic lipoprotein modifications in patients with primary iron overload.
Meroño T; Brites F; Dauteuille C; Lhomme M; Menafra M; Arteaga A; Castro M; Saez MS; Ballerga EG; Sorroche P; Rey J; Lesnik P; Sordá JA; Chapman MJ; Kontush A; Daruich J
Clin Sci (Lond); 2015 May; 128(9):609-18. PubMed ID: 25442240
[TBL] [Abstract][Full Text] [Related]
6. The prevalence of HFE C282Y gene mutation is increased in Spanish patients with porphyria cutanea tarda without hepatitis C virus infection.
Toll A; Celis R; Ozalla MD; Bruguera M; Herrero C; Ercilla MG
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1201-6. PubMed ID: 17062032
[TBL] [Abstract][Full Text] [Related]
7. An open population screening study for HFE gene major mutations proves the low prevalence of C282Y mutation in Central Italy.
Floreani A; Rosa Rizzotto E; Basso D; Navaglia F; Zaninotto M; Petridis I; DI Andrea O; Testa R; Marra M; Baldo V; Chiaramonte M
Aliment Pharmacol Ther; 2007 Aug; 26(4):577-86. PubMed ID: 17661761
[TBL] [Abstract][Full Text] [Related]
8. Analysis of HFE and TFR2 mutations in selected blood donors with biochemical parameters of iron overload.
De Gobbi M; Daraio F; Oberkanins C; Moritz A; Kury F; Fiorelli G; Camaschella C
Haematologica; 2003 Apr; 88(4):396-401. PubMed ID: 12681966
[TBL] [Abstract][Full Text] [Related]
9. HFE C282Y homozygosity is associated with lower total and low-density lipoprotein cholesterol: The hemochromatosis and iron overload screening study.
Adams PC; Pankow JS; Barton JC; Acton RT; Leiendecker-Foster C; McLaren GD; Speechley M; Eckfeldt JH
Circ Cardiovasc Genet; 2009 Feb; 2(1):34-7. PubMed ID: 20031565
[TBL] [Abstract][Full Text] [Related]
10. HFE gene mutations in Polish patients with disturbances of iron metabolism: an initial assessment.
Sikorska K; Bielawski KP; Stalke P; Lakomy EA; Michalska Z; Witczak-Malinowska K; Romanowski T
Int J Mol Med; 2005 Dec; 16(6):1151-6. PubMed ID: 16273299
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of HFE mutations among the Thai population and correlation with iron loading in haemoglobin E disorder.
Viprakasit V; Vathesathokit P; Chinchang W; Tachavanich K; Pung-Amritt P; Wimhurst VL; Yenchitsomanus PT; Merryweather-Clarke AT; Tanphaichitr VS
Eur J Haematol; 2004 Jul; 73(1):43-9. PubMed ID: 15182337
[TBL] [Abstract][Full Text] [Related]
12. HFE genotypes in decompensated alcoholic liver disease: phenotypic expression and comparison with heavy drinking and with normal controls.
Gleeson D; Evans S; Bradley M; Jones J; Peck RJ; Dube A; Rigby E; Dalton A
Am J Gastroenterol; 2006 Feb; 101(2):304-10. PubMed ID: 16454835
[TBL] [Abstract][Full Text] [Related]
13. Genotype screening for hereditary hemochromatosis among voluntary blood donors in Hungary.
Andrikovics H; Kalmár L; Bors A; Fandl B; Petri I; Kalász L; Tordai A
Blood Cells Mol Dis; 2001; 27(1):334-41. PubMed ID: 11358395
[TBL] [Abstract][Full Text] [Related]
14. Hemochromatosis and iron-overload screening in a racially diverse population.
Adams PC; Reboussin DM; Barton JC; McLaren CE; Eckfeldt JH; McLaren GD; Dawkins FW; Acton RT; Harris EL; Gordeuk VR; Leiendecker-Foster C; Speechley M; Snively BM; Holup JL; Thomson E; Sholinsky P;
N Engl J Med; 2005 Apr; 352(17):1769-78. PubMed ID: 15858186
[TBL] [Abstract][Full Text] [Related]
15. HFE gene mutations, hepatic iron content, and histological severity in hepatitis C virus-induced chronic hepatitis.
Ladero JM; Ropero P; Ortega L; Taxonera C; González FA; López-Alonso G; Briceño O; Rodríguez-Agulló JL; González L; Villegas A; Díaz-Rubio M
Rev Esp Enferm Dig; 2003 Dec; 95(12):829-36. PubMed ID: 14972004
[TBL] [Abstract][Full Text] [Related]
16. [Clinical study on relationship between JAK2 V617F mutation and chronic myeloproliferative disorders].
Zhang Y; Li L; Nie L; Yu Y; Yang YH; Zhang ZQ; Yang L; Xu SC; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2008 Feb; 29(2):105-9. PubMed ID: 18681311
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of JAK2 V617F mutation in Indian patients with chronic myeloproliferative disorders.
Sazawal S; Bajaj J; Chikkara S; Jain S; Bhargava R; Mahapatra M; Saxena R
Indian J Med Res; 2010 Oct; 132():423-7. PubMed ID: 20966521
[TBL] [Abstract][Full Text] [Related]
18. [Molecular genetic diagnostics and screening of hereditary hemochromatosis].
Zlocha J; Kovács L; Pozgayová S; Kupcová V; Durínová S
Vnitr Lek; 2006 Jun; 52(6):602-8. PubMed ID: 16871764
[TBL] [Abstract][Full Text] [Related]
19. Liver iron, HFE gene mutations, and hepatocellular carcinoma occurrence in patients with cirrhosis.
Nahon P; Sutton A; Rufat P; Ziol M; Thabut G; Schischmanoff PO; Vidaud D; Charnaux N; Couvert P; Ganne-Carrie N; Trinchet JC; Gattegno L; Beaugrand M
Gastroenterology; 2008 Jan; 134(1):102-10. PubMed ID: 18061182
[TBL] [Abstract][Full Text] [Related]
20. Transferrin receptor-2 gene and non-C282Y homozygous patients with hemochromatosis.
Aguilar-Martinez P; Esculié-Coste C; Bismuth M; Giansily-Blaizot M; Larrey D; Schved JF
Blood Cells Mol Dis; 2001; 27(1):290-3. PubMed ID: 11358390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
